Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.48 |
| ▸ | RARA | P10276 | 1/20 | 0.44 |
| ▸ | RARG | P13631 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.37 |
| ▸ | CHKA | P35790 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11957382 | 1.00 | RARB (0.48) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL30232659 | 1.00 | RARB (0.48) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL20202973 | 0.98 | RARB (0.47) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL20202986 | 0.98 | RARB (0.47) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL9512294 | 0.95 | RARB (0.51) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL10603849 | 0.95 | RARB (0.51) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL20202978 | 0.93 | RARB (0.50) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL20209761 | 0.93 | RARB (0.47) | RARBRARARARGTAAR1KIF11 | |
| SCHEMBL10329842 | 0.92 | RARB (0.46) | RARBRARARARGMCL1TAAR1 | |
| SCHEMBL16377212 | 0.92 | RARB (0.49) | RARBRARARARGMCL1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024665-B2 | Polymer-stabilized liquid crystal composition and use thereof | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) | 2024-07-02 | — | — | US | disclosed |
| US-12024665-B2 | Polymer-stabilized liquid crystal composition and use thereof | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) | 2024-07-02 | — | — | US | disclosed |
| US-20230287272-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | DIC CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-20220389320-A1 | POLYMER-STABILIZED LIQUID CRYSTAL COMPOSITION AND USE THEREOF | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD (CN) | 2022-12-08 | — | — | US | disclosed |
| WO-2021253621-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT, AND LIQUID CRYSTAL DISPLAY | 石家庄诚志永华显示材料有限公司 | 2021-12-23 | — | — | WO | disclosed |
| US-11162028-B2 | Liquid crystal composition and application thereof | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-11-02 | — | — | US | disclosed |
| US-20210017450-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE HAVING SAME | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-01-21 | — | — | US | disclosed |
| US-20200339884-A1 | LIQUID CRYSTAL COMPOSITION AND USE THEREOF | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-10-29 | — | — | US | disclosed |
| US-10723947-B2 | Liquid crystal composition and liquid crystal display device thereof | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-07-28 | — | — | US | disclosed |
| US-8741176-B2 | Liquid crystal compound | DAXIN MATERIALS CORPORATION (TW) | 2014-06-03 | — | — | US | disclosed |
| US-8741176-B2 | Liquid crystal compound | DAXIN MATERIALS CORPORATION (TW) | 2014-06-03 | — | — | US | disclosed |
| US-20120264984-A1 | LIQUID CRYSTAL COMPOUND | DAXIN MATERIALS CORPORATION (TW) | 2012-10-18 | — | — | US | disclosed |
| US-20120264984-A1 | LIQUID CRYSTAL COMPOUND | DAXIN MATERIALS CORPORATION (TW) | 2012-10-18 | — | — | US | disclosed |
| US-20120015115-A1 | DISPLAY PANEL | AU OPTRONICS CORPORATION (TW) | 2012-01-19 | — | — | US | disclosed |
| US-20120015115-A1 | DISPLAY PANEL | AU OPTRONICS CORPORATION (TW) | 2012-01-19 | — | — | US | disclosed |
| US-7390538-B2 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2008-06-24 | — | — | US | disclosed |
| US-7390538-B2 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2008-06-24 | — | — | US | disclosed |
| US-20070001149-A1 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070001149-A1 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | RARB 3196/4885RARA 3675/4885RARG 3904/4885 |
| US-20120264984-A1 | LIQUID CRYSTAL COMPOUND | PYM1, YBX3, RXFP3 | RARB 3225/4885RARA 2739/4885RARG 3133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.